Market Snapshot
| Study Period: | 2016 -2027 |
| Base Year: | 2021 |
| Fastest Growing Market: | North America |
| Largest Market: | Asia Pacific |
| CAGR: | 7.5 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The Global Nicotine Gum Market is projected to register a CAGR of 7.5% during the forecast period (2022-2027).
Tobacco smoking is a known risk factor for many respiratory infections, including COVID-19. A review of studies by WHO on 29 April 2020 found that smokers are more likely to develop severe diseases with COVID-19 compared to non-smokers. Thereby, Nicotine replacement therapies, such as gum and patches, were increasingly preferred during the pandemic.
The growing awareness regarding health hazards associated with smoking, which has resulted in a rise in the number of people trying to quit smoking, is the major factor driving the market growth. Moreover, the market has witnessed a significant increase in demand from medical institutions and rehab clinics for nicotine cessation in both developed and developing countries across the globe.
Furthermore, an increase in government initiatives across various countries to control tobacco consumption is also a prime factor in the rising sales of nicotine gum globally.
Scope of the Report
Nicotine gum is an over-the-counter (OTC) smoking cessation product. It aims to assist individuals suffering from tobacco dependence in minimizing their consumption of cigarettes and eventually quitting smoking. Nicotine is released when the gum is chewed and absorbed into the bloodstream through the lining of the mouth. The global nicotine gum market is segmented by product type into 2 mg Nicotine Gum and 4 mg Nicotine Gum. By distribution channel, the scope includes supermarkets/hypermarkets, convenience stores/tobacco stores, online retail stores, and other distribution channels. By geography, the scope includes North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The report offers market size and forecast for the nicotine gum market in value (USD million) for all the above segments.
| By Type | |
| 2 mg Nicotine Gum | |
| 4 mg Nicotine Gum |
| By Distribution Channels | |
| Supermarkets/Hypermarkets | |
| Convenience Stores/Tobacco Stores | |
| Online Retail Stores | |
| Other Distribution Channels |
| Geography | |||||||||
| |||||||||
| |||||||||
| |||||||||
| |||||||||
|
Key Market Trends
Rising Awareness Regarding Health Hazards Associated with Smoking
Globally, there has been a significant rise in government focus on reducing smoking rates. Governments across the regions are adopting comprehensive approaches to control tobacco consumption. This includes a range of measures such as a ban on tobacco advertising and promotion; restrictions on smoking in public places and the workplace; sustained increases in tobacco taxation combined with efforts to curb smuggling; large, bold health warnings on tobacco products; smoking cessation and health education campaigns; and the regulation of tobacco to standards and many others. Such measures have increased the consumers to look for alternatives to reduce tobacco consumption driving demand for the nicotine gum market.
To understand key trends, Download Sample Report
North America Holds Significant Share in the Market
North America has experienced an increase in the percentage of health consciousness consumers supported by government initiatives and campaigns driving the growth of the market in the region. Moreover, the region has the presence of major brands focusing on product innovations to capture the growing demand and achieve a competitive advantage in the market. For instance, Nicorette has launched a new nicotine gum product coated ice mint lozenge with a smoother texture. Such factors are anticipated to drive the market growth during the study period. The United States holds the major share in the North American nicotine gum market.
To understand geography trends, Download Sample Report
Competitive Landscape
The global nicotine gum market is highly competitive with the presence of various regional and global players. Moreover, the market has the presence of many private label nicotine gum brands owing to growing demand. Companies make themselves competitive by expanding product offerings, and improving taste, flavors, functionality, and marketing activities. Key players in the market include GlaxoSmithKline plc, ITC Limited, and Johnson & Johnson, among others.
Recent Development
- In February 2022, Enorama Pharma’s business partner, betapharm Arzneimittel GmbH, has launched the first generic nicotine chewing gum on the German market under the brand name Nicotin beta. Nicotin beta will offer a generic product underlining the advantages of NRT (Nicotine Replacement Therapy).
- In August 2021, GSK launched Nicotinell which is a smoking cessation treatment range that includes patch, gum and lozenge. It is designed to help smokers quit their nicotine addiction.
- In July 2021, Philip Morris International Inannounced that the company would buy nicotine gum maker Fertin Pharma from private equity firm EQT for DKK5.1 billion.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 2 mg Nicotine Gum
5.1.2 4 mg Nicotine Gum
5.2 By Distribution Channels
5.2.1 Supermarkets/Hypermarkets
5.2.2 Convenience Stores/Tobacco Stores
5.2.3 Online Retail Stores
5.2.4 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Spain
5.3.2.2 United Kingdom
5.3.2.3 Germany
5.3.2.4 France
5.3.2.5 Italy
5.3.2.6 Russia
5.3.2.7 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East and Africa
5.3.5.1 South Africa
5.3.5.2 United Arab Emirates
5.3.5.3 Rest of Middle-East and Africa
6. COMPETITIVE LANDSCAPE
6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 British American Tobacco
6.3.2 GlaxoSmithKline plc
6.3.3 ITC Limited
6.3.4 Johnson & Johnson
6.3.5 Perrigo Company plc
6.3.6 Takeda Consumer Healthcare Company Limited
6.3.7 Fertin Pharma
6.3.8 Alchem International Pvt. Limited
6.3.9 Cipla Health Limited
6.3.10 Dr Reddy’s Laboratories
*List Not Exhaustive7. MARKET OPPORTUNITIES AND FUTURE TRENDS
8. IMPACT OF COVID-19 ON THE MARKET
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Nicotine Gum Market market is studied from 2016 - 2027.
What is the growth rate of Nicotine Gum Market?
The Nicotine Gum Market is growing at a CAGR of 7.5% over the next 5 years.
What is Nicotine Gum Market size in 2016?
The Nicotine Gum Market is valued at 5 Billion USD in 2016.
Which region has highest growth rate in Nicotine Gum Market?
North America is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Nicotine Gum Market?
Asia Pacific holds highest share in 2021.
Who are the key players in Nicotine Gum Market?
ITC Limited, Johnson & Johnson, GlaxoSmithKline plc, Cipla Inc, Perrigo Company plc are the major companies operating in Nicotine Gum Market.
